id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CMS-2022-0119-17019,CMS,CMS-2022-0119,"Clinical Laboratory Improvement Amendments Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories; Extension of Comment Period",Proposed Rule,,2022-08-29T04:00:00Z,2022,8,,,2022-08-29T13:26:59Z,2022-18558,0,0,0900006485285315
CMS-2022-0119-0001,CMS,CMS-2022-0119,"Clinical Laboratory Improvement Amendments Fees: Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories",Proposed Rule,,2022-07-26T04:00:00Z,2022,7,2022-07-26T04:00:00Z,2022-09-27T03:59:59Z,2022-09-28T01:01:00Z,2022-15300,0,0,09000064851e8f95